EXPLORE CONNECTIONS
Levetiracetam prevents Aβ42 production through SV2a-dependent modulation of App processing in Alzheimer's disease models
Follow the relationships that help you find your next source.
Connections are not prepared for this record yet, or its source metadata has changed. The original record remains available while background snapshots are rebuilt.